| Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival AHG Cleven, GA Al Sannaa, I Briaire-de Bruijn, DR Ingram, ... Modern pathology 29 (6), 582-590, 2016 | 190 | 2016 |
| Patterns of recurrence and survival in sporadic, neurofibromatosis type 1–associated, and radiation-associated malignant peripheral nerve sheath tumors KL Watson, GA Al Sannaa, CM Kivlin, DR Ingram, SM Landers, ... Journal of neurosurgery 126 (1), 319-329, 2017 | 119 | 2017 |
| Progressive loss of myogenic differentiation in leiomyosarcoma has prognostic value EG Demicco, GM Boland, KJ Brewer Savannah, K Lusby, ED Young, ... Histopathology 66 (5), 627-638, 2015 | 44 | 2015 |
| Program for lung cancer screening and tobacco cessation: study protocol of a sequential, multiple assignment, randomized trial SS Fu, AJ Rothman, DM Vock, B Lindgren, D Almirall, A Begnaud, ... Contemporary clinical trials 60, 86-95, 2017 | 39 | 2017 |
| Clinical observations and molecular variables of primary vascular leiomyosarcoma CL Roland, GM Boland, EG Demicco, K Lusby, D Ingram, CD May, ... JAMA surgery 151 (4), 347-354, 2016 | 33 | 2016 |
| Analysis of clinical and molecular factors impacting oncologic outcomes in undifferentiated pleomorphic sarcoma CL Roland, CD May, KL Watson, GA Al Sannaa, SP Dineen, R Feig, ... Annals of surgical oncology 23, 2220-2228, 2016 | 32 | 2016 |
| PET/CT imaging as a diagnostic tool in distinguishing well-differentiated versus dedifferentiated liposarcoma A Parkes, E Urquiola, P Bhosale, H Lin, K Watson, WL Wang, B Feig, ... Sarcoma 2020, 2020 | 25 | 2020 |
| Co-targeting PI3K, mTOR, and IGF1R with small molecule inhibitors for treating undifferentiated pleomorphic sarcoma CD May, SM Landers, S Bolshakov, XY Ma, DR Ingram, CM Kivlin, ... Cancer biology & therapy 18 (10), 816-826, 2017 | 23 | 2017 |
| Incidental findings in a decentralized lung cancer screening program K Janssen, K Schertz, N Rubin, A Begnaud Annals of the American Thoracic Society 16 (9), 1198-1201, 2019 | 16 | 2019 |
| Sarcoma brain metastases: 28 years of experience at a single institution G Al Sannaa, KL Watson, A Olar, WL Wang, GN Fuller, I McCutcheon, ... Annals of surgical oncology 23, 962-967, 2016 | 16 | 2016 |
| Poly (ADP) ribose polymerase inhibition: A potential treatment of malignant peripheral nerve sheath tumor CM Kivlin, KL Watson, GA Al Sannaa, R Belousov, DR Ingram, KL Huang, ... Cancer Biology & Therapy 17 (2), 129-138, 2016 | 14 | 2016 |
| Identification of preoperative factors associated with outcomes following surgical management of intra‐abdominal recurrent or metastatic GIST following neoadjuvant tyrosine … CL Roland, BK Bednarski, K Watson, KE Torres, JN Cormier, WL Wang, ... Journal of surgical oncology 117 (5), 879-885, 2018 | 12 | 2018 |
| What Becomes of America’s Military Brats? K Schertz, C Watson American journal of public health 108 (7), 837-837, 2018 | 6 | 2018 |
| Primary vascular leiomyosarcoma: clinical observations and molecular variables CL Roland, GM Boland, EG Demicco, K Lusby, D Ingram, CD May, ... JAMA surgery 151 (4), 347, 2016 | 5 | 2016 |
| Impact of 2016 SCCT/STR guidelines for coronary artery calcium scoring of noncardiac chest CT scans on lung cancer screening CT reporting PS Velangi, B Kenny, M Hooks, A Kanda, K Schertz, H Kharoud, ... The International Journal of Cardiovascular Imaging 37, 2777-2784, 2021 | 3 | 2021 |
| Optimizing Longitudinal Tobacco Cessation Treatment in Lung Cancer Screening: A Sequential, Multiple Assignment, Randomized Trial SS Fu, AJ Rothman, DM Vock, BR Lindgren, D Almirall, A Begnaud, ... JAMA Network Open 6 (8), e2329903-e2329903, 2023 | 2 | 2023 |
| Self-reported exercise capacity among current smokers eligible for lung cancer screening: distribution and association with key comorbidities AC Melzer, A Begnaud, BR Lindgren, K Schertz, SS Fu, DM Vock, ... Cancer treatment and research communications 28, 100443, 2021 | 2 | 2021 |
| Functional Status Among Current Smokers Referred for Lung Cancer Screening: Distribution and Association with Key Comorbidities AC Melzer, A Begnaud, KL Schertz, SS Fu, D Vock, AJ Rothman, ... C99. LUNG CANCER SCREENING-INSIGHTS ON RISK ASSESSMENT, COMORBIDITIES, AND …, 2020 | 1 | 2020 |
| Disclosure of suicidal ideation in non-psychiatric clinical research: Experience using a novel suicide risk management algorithm in a multi-center smoking cessation trial KL Schertz, M Petrik, M Branson, SS Fu, AJ Rothman, A Begnaud, ... Research Methods in Medicine & Health Sciences, 26320843231212427, 2023 | | 2023 |
| Latent constructs identified in older individuals who smoke cigarettes and are eligible for lung cancer screening: Factor analysis of baseline data from the PLUTO smoking … A Begnaud, SS Fu, B Lindgren, A Melzer, AJ Rothman, K Schertz, ... Contemporary Clinical Trials Communications 29, 100977, 2022 | | 2022 |
